Radek Trojanec
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
-
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 4
- Co-authors
- Marián Hajdúch (31 shared papers)Vladimíra Koudeláková (10 shared papers)Zdeněk Kolář (11 shared papers)Kateřina Bouchalová (14 shared papers)Karel Cwiertka (11 shared papers)Jiří Ehrmann (9 shared papers)Jir̆ı́ Drábek (7 shared papers)Ondřej Kalita (9 shared papers)
In The Last Decade
Radek Trojanec
37 papers receiving 639 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 191
- Oncology 284
- Genetics 67
- Pulmonary and Respiratory Medicine 150
- Molecular Biology 281
Countries citing papers authored by Radek Trojanec
This map shows the geographic impact of Radek Trojanec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radek Trojanec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radek Trojanec more than expected).
Fields of papers citing papers by Radek Trojanec
This network shows the impact of papers produced by Radek Trojanec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radek Trojanec. The network helps show where Radek Trojanec may publish in the future.
Co-authors
The 25 scholars most cited alongside Radek Trojanec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 164 | |
| 2 | 2008 | 76 | |
| 3 | In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells. | 2002 | 51 |
| 4 | 2009 | 42 | |
| 5 | 2013 | 33 | |
| 6 | 2015 | 29 | |
| 7 | 2008 | 23 | |
| 8 | 2010 | 19 | |
| 9 | 2010 | 19 | |
| 10 | 2014 | 19 | |
| 11 | 2010 | 18 | |
| 12 | Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer. | 2006 | 17 |
| 13 | 2015 | 16 | |
| 14 | 2017 | 16 | |
| 15 | 2008 | 15 | |
| 16 | 2010 | 14 | |
| 17 | 2006 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2014 | 10 | |
| 20 | 2014 | 6 |
About Radek Trojanec
Radek Trojanec is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 37 papers that have together received 658 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (8 papers), Glioma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cancer Research (191 citations), Oncology (284 citations), Genetics (67 citations), Pulmonary and Respiratory Medicine (150 citations) and Molecular Biology (281 citations). Radek Trojanec has collaborated with scholars based in Czechia, Slovakia and Taiwan. Frequent co-authors include Marián Hajdúch, Vladimíra Koudeláková, Zdeněk Kolář, Kateřina Bouchalová, Karel Cwiertka, Jiří Ehrmann, Jir̆ı́ Drábek, Ondřej Kalita, Magdalena Čížková and Gabriela Kořínková. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Breast Cancer Research, Clinical Neurology and Neurosurgery and Experimental and Molecular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.